MTVA (metaviatx.com) Quarterly EPS earnings growth
MetaVia Inc is betting on internal development and targeted licenses. The business is not subject to cycles, as success depends on the stages of scientific research. The quarterly EPS trend in the GURU.Markets interface is illustrated by this chart, where the 69.00 indicator reflects the status of profit dynamics. The company's future monopoly pricing power is ensured by the exclusivity of its patents.
%20Year-over-year%20net%20earnings%20per%20share%20change%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261111&filename=GURU_Markets_-_MTVA_-_MetaVia-Inc_-_Year-over-year-net-earnings-per-share-change-for-the-last-twelve-months "MTVA MetaVia Inc: Quarterly EPS earnings growth in the range 11/30/2024 - 11/11/2026 | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for MetaVia Inc (MTVA)
- share price and consensus valuation forecast:
- business market valuation indicators:
- balance sheet net asset value indicators:
- debt level and financial liquidity data:
Total Debt to Capital MetaVia Inc|MTVA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity metaviatx.com|MTVA - Company Aggregate Debt|Debts to Book Capitalization MetaVia Inc|MTVA - Company Long-Term Liabilities|Company Short-Term Debt MetaVia|Quick Liquidity Indicator metaviatx.com
- earnings and valuation multiples indicators:
MTVA - Profit After Payment of Taxes|Future Profit MetaVia Inc|MTVA - Price to Earnings Ratio|Forward P/E Multiple metaviatx.com|MTVA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MetaVia Inc|MTVA - Operating profit before amortization|Net earnings per share (EPS TTM) MetaVia|MTVA - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months metaviatx.com|MTVA - Earnings growth in current year|Net earnings per share growth forecast for next year MetaVia Inc
Summary company analysis:MetaVia Inc. - MTVA
An investment audit of MetaVia Inc (MTVA) requires an analysis of net earnings per share dynamics, where the metric calculates the percentage change in current EPS relative to the same quarter of the previous year to assess business scaling rates. Given the company's focus on preclinical research and patenting, the quarterly EPS growth trend reflects a high-expenditure stage, allowing for the timely recognition of capital degradation risks.
Main competitors
BIIB (Biogen) - Year-over-year net earnings per share growth for the last 12 months|NBIX (Neurocrine) - Year-over-year earnings per share growth for the last twelve months|RGC (Regencell) - Quarterly EPS earnings growth|Axsome Corp (AXSM) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth ACAD|Quarterly EPS earnings growth xenon-pharma.com (XENE)|Viking Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SUPN|Catalyst Pharmaceuticals Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Denali Corp DNLI|Harmony Biosciences (HRMY) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months BHVN|AMLX (Amylyx Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Trevi Therapeutics Inc (TRVI)|Year-over-year earnings per share growth for the last twelve months Praxis Medicines (PRAX)|Year-over-year net earnings per share growth for the last 12 months Anavex Life Sciences Corp AVXL|CeriBell, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months PRTA (prothena.com)|ALEC: Year-over-year net earnings per share growth for the last 12 months|ANNX: Year-over-year earnings per share growth for the last twelve months|OMER: Quarterly EPS earnings growth|Neurogene Therapeutics (NGNE) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months AC Immune|Year-over-year earnings per share growth for the last 12 months VYGR (voyagertherapeutics.com)|Quarterly EPS earnings growth NMRA|SCLX - Earnings per share growth in annualized terms for the last twelve months|Tevogen Bio Holdings, Inc. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Alpha Cognition Inc ACOG|CGTX - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IKT (inhibikase.com)|Cassava Sciences (SAVA) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Assertio (ASRT)|Year-over-year earnings per share growth for the last twelve months Coya Therapeutics Inc|Year-over-year net earnings per share growth for the last 12 months VistaGen Therapeutics Inc (VTGN)|Quarterly EPS earnings growth OVID|ABOS - Earnings per share growth in annualized terms for the last twelve months|CervoMed - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ATHE (Alterity Therapeutics Ltd.)|Clene Nanomedicine - Quarterly EPS earnings growth|PEPG - Quarterly EPS earnings growth|JUNS (Jupiter Neurosciences) - Year-over-year net earnings per share growth for the last 12 months|RLMD (relmada.com) - Year-over-year earnings per share growth for the last twelve months|ANVS (Annovis Bio) - Quarterly EPS earnings growth|Grace Tx (GRCE) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth AIFF|Quarterly EPS earnings growth anewmeds.com (KLTO)|NeuroSense Therapeutics Ltd. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months RVPH|NeurAxis - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Helius Medical HSDT|passagebio.com (PASG) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months NEUP|NERV (Minerva Neurosciences) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months athira.com (ATHA)|Year-over-year earnings per share growth for the last twelve months Addex Therapeutics Ltd (ADXN)|Year-over-year net earnings per share growth for the last 12 months alzamend.com ALZN|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months PTIX (Protagenic Therapeutics Inc.)|KTTA: Year-over-year net earnings per share growth for the last 12 months|CRGT: Year-over-year earnings per share growth for the last twelve months|ATXI: Quarterly EPS earnings growth|Brainstorm Cell Therapeutics Inc. (BCLI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Cara Therapeutics, Inc|Year-over-year earnings per share growth for the last 12 months CHRO (Chromocell)|Quarterly EPS earnings growth ELYM|ITCI - Earnings per share growth in annualized terms for the last twelve months|Longboard Pharmaceuticals, Inc. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Marinus Pharmaceuticals Inc MRNS|NKGN - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months NRBO (NeuroBo Pharma)|Sage Therapeutics, Inc. (SAGE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months synaptogen.com (SNPX)|Year-over-year earnings per share growth for the last twelve months Trevena|Year-over-year net earnings per share growth for the last 12 months Vigil Neuro (VIGL)|Quarterly EPS earnings growth WENA|CERE - Earnings per share growth in annualized terms for the last twelve months
